Optimisation of induction conditions for a bacterial strain producing proinsulin aspart

Diabetes poses a serious threat to the health of people around the world. Therefore, in 2021, the World Health Organisation launched the Global Diabetes Compact, an initiative aimed at improving the management and prevention of diabetes. The rapid growth in the number of diabetic patients has increa...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Kornakov, Z. R. Khasanshina, D. A. Senichkina, A. A. Filipenko, I. S. Lunev, R. V. Drai
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2023-06-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/438
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839581779275546624
author I. A. Kornakov
Z. R. Khasanshina
D. A. Senichkina
A. A. Filipenko
I. S. Lunev
R. V. Drai
author_facet I. A. Kornakov
Z. R. Khasanshina
D. A. Senichkina
A. A. Filipenko
I. S. Lunev
R. V. Drai
author_sort I. A. Kornakov
collection DOAJ
description Diabetes poses a serious threat to the health of people around the world. Therefore, in 2021, the World Health Organisation launched the Global Diabetes Compact, an initiative aimed at improving the management and prevention of diabetes. The rapid growth in the number of diabetic patients has increased the need for insulin. Rapid-acting human insulin analogues, including insulin aspart, improve the efficacy of insulin therapy. Methods for insulin aspart production include its biosynthesis in the proinsulin form in Escherichia coli. However, the yield of the recombinant protein largely depends on the optimisation of the production process.The aim of the study was to optimise the induction conditions for an E. coli strain expressing recombinant proinsulin aspart through applying the Design of Experiment (DoE) approach to enhance bacterial cell productivity.Materials and methods. The study focused on a strain of E. coli producing proinsulin aspart. The authors planned the experiment using MODDE software and the reduced face-centred central composite design (CCF) enabling the assessment of factor interactions and the creation of design spaces. The authors carried out fermentations of the producing strain in a 5 L Biostat® B bioreactor and measured proinsulin aspart concentrations by capillary gel electrophoresis. The results were analysed using GraphPad Prism 6.Results. Using the DoE approach, the authors optimised the conditions for the growth of the producer strain and the biosynthesis of proinsulin aspart. Based on data from response surface plots for wet biomass concentration, specific productivity, and volumetric productivity, as well as plotted models, the authors established design spaces for the induction of proinsulin aspart expression in E. coli. The plotted models demonstrated high predictive power and high reproducibility of the results. The authors successfully validated the induction process for the synthesis of proinsulin aspart in a bioreactor under optimised conditions. The volumetric productivity of the strain producing proinsulin aspart increased from 3.06±0.16 g/L (conventional conditions) to 4.93±0.80 g/L (optimised conditions).Conclusions. The authors achieved a 60% increase in the volumetric yield of proinsulin aspart. The study results may be used to intensify the industrial production of insulin aspart.
format Article
id doaj-art-a4cce2e6d1634b1c9e00900dc7053da5
institution Matheson Library
issn 2221-996X
2619-1156
language Russian
publishDate 2023-06-01
publisher Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Биопрепараты: Профилактика, диагностика, лечение
spelling doaj-art-a4cce2e6d1634b1c9e00900dc7053da52025-08-04T10:16:03ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562023-06-0123221923010.30895/2221-996X-2023-23-2-219-230323Optimisation of induction conditions for a bacterial strain producing proinsulin aspartI. A. Kornakov0Z. R. Khasanshina1D. A. Senichkina2A. A. Filipenko3I. S. Lunev4R. V. Drai5Pharmholding CJSCPharmholding CJSCPharmholding CJSCPharmholding CJSCPharmholding CJSCPharmholding CJSCDiabetes poses a serious threat to the health of people around the world. Therefore, in 2021, the World Health Organisation launched the Global Diabetes Compact, an initiative aimed at improving the management and prevention of diabetes. The rapid growth in the number of diabetic patients has increased the need for insulin. Rapid-acting human insulin analogues, including insulin aspart, improve the efficacy of insulin therapy. Methods for insulin aspart production include its biosynthesis in the proinsulin form in Escherichia coli. However, the yield of the recombinant protein largely depends on the optimisation of the production process.The aim of the study was to optimise the induction conditions for an E. coli strain expressing recombinant proinsulin aspart through applying the Design of Experiment (DoE) approach to enhance bacterial cell productivity.Materials and methods. The study focused on a strain of E. coli producing proinsulin aspart. The authors planned the experiment using MODDE software and the reduced face-centred central composite design (CCF) enabling the assessment of factor interactions and the creation of design spaces. The authors carried out fermentations of the producing strain in a 5 L Biostat® B bioreactor and measured proinsulin aspart concentrations by capillary gel electrophoresis. The results were analysed using GraphPad Prism 6.Results. Using the DoE approach, the authors optimised the conditions for the growth of the producer strain and the biosynthesis of proinsulin aspart. Based on data from response surface plots for wet biomass concentration, specific productivity, and volumetric productivity, as well as plotted models, the authors established design spaces for the induction of proinsulin aspart expression in E. coli. The plotted models demonstrated high predictive power and high reproducibility of the results. The authors successfully validated the induction process for the synthesis of proinsulin aspart in a bioreactor under optimised conditions. The volumetric productivity of the strain producing proinsulin aspart increased from 3.06±0.16 g/L (conventional conditions) to 4.93±0.80 g/L (optimised conditions).Conclusions. The authors achieved a 60% increase in the volumetric yield of proinsulin aspart. The study results may be used to intensify the industrial production of insulin aspart.https://www.biopreparations.ru/jour/article/view/438diabetesproinsulininsulin aspartinduction conditions<i>escherichia coli</i>design of experiments
spellingShingle I. A. Kornakov
Z. R. Khasanshina
D. A. Senichkina
A. A. Filipenko
I. S. Lunev
R. V. Drai
Optimisation of induction conditions for a bacterial strain producing proinsulin aspart
Биопрепараты: Профилактика, диагностика, лечение
diabetes
proinsulin
insulin aspart
induction conditions
<i>escherichia coli</i>
design of experiments
title Optimisation of induction conditions for a bacterial strain producing proinsulin aspart
title_full Optimisation of induction conditions for a bacterial strain producing proinsulin aspart
title_fullStr Optimisation of induction conditions for a bacterial strain producing proinsulin aspart
title_full_unstemmed Optimisation of induction conditions for a bacterial strain producing proinsulin aspart
title_short Optimisation of induction conditions for a bacterial strain producing proinsulin aspart
title_sort optimisation of induction conditions for a bacterial strain producing proinsulin aspart
topic diabetes
proinsulin
insulin aspart
induction conditions
<i>escherichia coli</i>
design of experiments
url https://www.biopreparations.ru/jour/article/view/438
work_keys_str_mv AT iakornakov optimisationofinductionconditionsforabacterialstrainproducingproinsulinaspart
AT zrkhasanshina optimisationofinductionconditionsforabacterialstrainproducingproinsulinaspart
AT dasenichkina optimisationofinductionconditionsforabacterialstrainproducingproinsulinaspart
AT aafilipenko optimisationofinductionconditionsforabacterialstrainproducingproinsulinaspart
AT islunev optimisationofinductionconditionsforabacterialstrainproducingproinsulinaspart
AT rvdrai optimisationofinductionconditionsforabacterialstrainproducingproinsulinaspart